| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth.
|
J Biol Chem
|
1997
|
1.68
|
|
2
|
Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
|
J Biol Chem
|
1996
|
1.63
|
|
3
|
Siderochromes from Pseudomonas fluorescens. I. Isolation and characterization.
|
J Biol Chem
|
1982
|
1.59
|
|
4
|
Structural analysis of BAG1 cochaperone and its interactions with Hsc70 heat shock protein.
|
Nat Struct Biol
|
2001
|
1.43
|
|
5
|
Siderochromes from Pseudomonas fluorescens. II. Structural homology as revealed by NMR spectroscopy.
|
J Biol Chem
|
1982
|
1.30
|
|
6
|
Solution conformation of ferrichrome, a microbial iron transport cyclohexapeptide, as deduced by high resolution proton magnetic resonance.
|
J Mol Biol
|
1970
|
1.29
|
|
7
|
Proton magnetic resonance study of crambin, a hyperstable hydrophobic protein, at 250 and 600 MHz.
|
Biochemistry
|
1980
|
1.10
|
|
8
|
ABACUS, a direct method for protein NMR structure computation via assembly of fragments.
|
Proteins
|
2005
|
1.10
|
|
9
|
Effect of metal binding on the conformation of enterobactin. A proton and carbon-13 nuclear magnetic resonance study.
|
Biochemistry
|
1973
|
1.08
|
|
10
|
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
|
FASEB J
|
1998
|
1.05
|
|
11
|
The second type II module from human matrix metalloproteinase 2: structure, function and dynamics.
|
Structure
|
1999
|
1.00
|
|
12
|
Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains.
|
Biochemistry
|
1999
|
0.99
|
|
13
|
Gelatin-binding region of human matrix metalloproteinase-2: solution structure, dynamics, and function of the COL-23 two-domain construct.
|
J Biol Chem
|
2001
|
0.96
|
|
14
|
Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin.
|
Proteins
|
1988
|
0.93
|
|
15
|
The solution conformation of the ferrichromes. V. The hydrogen exchange kinetics of ferrichrome analogues; the conformational state of the peptides.
|
J Biol Chem
|
1973
|
0.93
|
|
16
|
Domain organization of the 39-kDa receptor-associated protein.
|
J Biol Chem
|
1999
|
0.93
|
|
17
|
Ligand interactions with the kringle 5 domain of plasminogen. A study by 1H NMR spectroscopy.
|
J Biol Chem
|
1990
|
0.92
|
|
18
|
Nitrogen-15 nuclear magnetic resonance spectrum of alumichrome. Detection by a double resonance Fourier transform technique.
|
J Am Chem Soc
|
1976
|
0.91
|
|
19
|
Heparin binding to the urokinase kringle domain.
|
Biochemistry
|
1992
|
0.90
|
|
20
|
Amide proton spin-lattice relaxation in polypeptides. A field-dependence study of the proton and nitrogen dipolar interactions in alumichrome.
|
Biophys J
|
1978
|
0.90
|
|
21
|
The two polypeptide chains in fibronectin are joined in antiparallel fashion: NMR structural characterization.
|
Biochemistry
|
1992
|
0.89
|
|
22
|
Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
|
Biochem Biophys Res Commun
|
1998
|
0.88
|
|
23
|
Refined solution structure and ligand-binding properties of PDC-109 domain b. A collagen-binding type II domain.
|
J Mol Biol
|
1992
|
0.87
|
|
24
|
Origin of fibronectin type II (FN2) modules: structural analyses of distantly-related members of the kringle family idey the kringle domain of neurotrypsin as a potential link between FN2 domains and kringles.
|
Protein Sci
|
2001
|
0.87
|
|
25
|
Protonated amino acid precursor studies on rhodotorulic acid biosynthesis in deuterium oxide media.
|
Biochemistry
|
1972
|
0.87
|
|
26
|
Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug.
|
J Mol Biol
|
1991
|
0.86
|
|
27
|
Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
|
Biochemistry
|
1997
|
0.85
|
|
28
|
Complete assignment of carbon signals in a stereospecific peptide via selective and single off-resonance proton decoupling experiments. Analysis of the carbon-13 nuclear magnetic resonance spectrum of alumichrome at 67.88 MHz.
|
Biochemistry
|
1979
|
0.84
|
|
29
|
Sequence-specific 1H NMR assignments and structural characterization of bovine seminal fluid protein PDC-109 domain b.
|
Biochemistry
|
1991
|
0.84
|
|
30
|
15N nuclear magnetic resonance of living cells.
|
Nature
|
1975
|
0.84
|
|
31
|
A carbon-13 spin lattice relaxation study of alumichrome at 25.1 MHz and 90.5 MHz.
|
Biochim Biophys Acta
|
1977
|
0.84
|
|
32
|
Kringle solution structures via NMR: two-dimensional 1H-NMR analysis of horse plasminogen kringle 4.
|
Chem Phys Lipids
|
1994
|
0.83
|
|
33
|
Isolation, purification and 1H-NMR characterization of a kringle 5 domain fragment from human plasminogen.
|
Biochim Biophys Acta
|
1987
|
0.83
|
|
34
|
Solution conformation of the ferrichromes. A comparative proton magnetic resonance study of glycine- and serine-containing ferrichromes.
|
J Mol Biol
|
1972
|
0.83
|
|
35
|
Ligand binding to the tissue-type plasminogen activator kringle 2 domain: structural characterization by 1H-NMR.
|
Biochemistry
|
1995
|
0.83
|
|
36
|
The structure of two alanine containing ferrichromes: sequence determination by proton magnetic resonance.
|
Biophys Struct Mech
|
1976
|
0.82
|
|
37
|
Ligand specificity of human plasminogen kringle 4.
|
Biochemistry
|
1991
|
0.82
|
|
38
|
Solution structure of the epsilon-aminohexanoic acid complex of human plasminogen kringle 1.
|
Eur J Biochem
|
1994
|
0.82
|
|
39
|
Peptide hydrogen bonding. Conformation dependence of the carbonyl carbon-13 nuclear magnetic resonance chemical shifts in ferrichrome. A study by 13C-[15N] Fourier double resonance spectroscopy1a.
|
J Am Chem Soc
|
1977
|
0.82
|
|
40
|
Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
|
Biochemistry
|
1996
|
0.81
|
|
41
|
A nitrogen-15 spin-lattice relaxation study of alumichrome.
|
Biochim Biophys Acta
|
1978
|
0.81
|
|
42
|
Peptide strain. Conformation dependence of the carbon-13 nuclear magnetic resonance chemical shifts in the ferrichromes.
|
J Am Chem Soc
|
1977
|
0.81
|
|
43
|
Tissue-type plasminogen activator domain-deletion mutant BM 06.022: modular stability, inhibitor binding, and activation cleavage.
|
Biochemistry
|
1994
|
0.81
|
|
44
|
Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: structure of the ligand-binding site.
|
Biochemistry
|
1987
|
0.81
|
|
45
|
Exploring functional genomics for drug target and therapeutics discovery in Plasmodia.
|
Acta Trop
|
2007
|
0.80
|
|
46
|
The solution conformation of the ferrichromes. IV. pH dependence of the individual slow amide hydrogen-deuterium exchange in alumichrome.
|
J Biol Chem
|
1973
|
0.80
|
|
47
|
Proton Overhauser experiments on kringle 4 from human plasminogen. Implications for the structure of the kringles' hydrophobic core.
|
Biochim Biophys Acta
|
1985
|
0.79
|
|
48
|
Proton magnetic resonance study of lysine-binding to the kringle 4 domain of human plasminogen. The structure of the binding site.
|
J Mol Biol
|
1987
|
0.79
|
|
49
|
Solution structure of the kringle domain from urokinase-type plasminogen activator.
|
J Mol Biol
|
1994
|
0.79
|
|
50
|
Proton magnetic resonance characterization of phoratoxins and homologous proteins related to crambin.
|
Biochemistry
|
1987
|
0.79
|
|
51
|
1H NMR studies of aliphatic ligand binding to human plasminogen kringle 4.
|
Biochemistry
|
1989
|
0.79
|
|
52
|
Inhibition of tumor growth by plasminogen-related protein-B.
|
Anticancer Res
|
2001
|
0.78
|
|
53
|
The solution conformation of the ferrichromes. II. Proton magnetic resonance of metal-free ferricrocin and ferrichrysin, conformational implications.
|
Int J Pept Protein Res
|
1972
|
0.78
|
|
54
|
Plasminogen kringle 4 binds the heptapeptide fragment 44-50 of the plasminogen N-terminal peptide.
|
Blood Coagul Fibrinolysis
|
1995
|
0.78
|
|
55
|
Human plasminogen. Proton NMR studies on kringle 1.
|
J Biol Chem
|
1982
|
0.78
|
|
56
|
Analysis and identification of aromatic signals in the proton magnetic resonance spectrum of the kringle 4 fragment from human plasminogen.
|
Biochemistry
|
1985
|
0.78
|
|
57
|
Computer-assisted assignment of 2D 1H NMR spectra of proteins: basic algorithms and application to phoratoxin B.
|
J Biomol NMR
|
1991
|
0.78
|
|
58
|
Proton magnetic resonance studies of barley and wheat thionins: structural homology with crambin.
|
Biochemistry
|
1982
|
0.77
|
|
59
|
Analysis of ligand-binding to the kringle 4 fragment from human plasminogen.
|
Eur Biophys J
|
1987
|
0.77
|
|
60
|
Human plasminogen kringle 4. Crystallization and preliminary diffraction data of two different crystal forms.
|
J Biol Chem
|
1989
|
0.77
|
|
61
|
1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator.
|
Biochemistry
|
1989
|
0.77
|
|
62
|
Ligand-binding effects on the kringle 4 domain from human plasminogen: a study by laser photo-CIDNP 1H-NMR spectroscopy.
|
Biochim Biophys Acta
|
1989
|
0.77
|
|
63
|
1H NMR characterization of the urokinase kringle module. Structural, but not functional, relatedness to homologous domains.
|
J Biol Chem
|
1993
|
0.77
|
|
64
|
Solvent and temperature effects on crambin, a hydrophobic protein, as investigated by proton magnetic resonance.
|
Eur J Biochem
|
1981
|
0.76
|
|
65
|
1H-NMR assignments and secondary structure of human plasminogen kringle 1.
|
Eur J Biochem
|
1994
|
0.76
|
|
66
|
Analysis of the aromatic 1H-NMR spectrum of the kringle 5 domain from human plasminogen. Evidence for a conserved kringle fold.
|
Eur J Biochem
|
1988
|
0.76
|
|
67
|
Solvent and temperature effects on crambin, a hydrophobic protein.
|
Biophys J
|
1980
|
0.75
|
|
68
|
1H-n.m.r. studies of the fibronectin 13 kDa collagen-binding fragment. Evidence for autonomous conserved type I and type II domain folds.
|
Biochem J
|
1992
|
0.75
|
|
69
|
Macro- and micro-stabilities of the kringle 4 domain from plasminogen. The effect of ligand binding.
|
Biophys J
|
1985
|
0.75
|
|
70
|
Kringle 4 from human plasminogen: a proton magnetic resonance study via two-dimensional photochemically induced dynamic nuclear polarization spectroscopy.
|
Biochemistry
|
1986
|
0.75
|
|
71
|
Synthesis, biological activity, and solution structures of a cyclic dodecapeptide from the EGF-2 domain of blood coagulation factor VII.
|
J Pept Res
|
2001
|
0.75
|
|
72
|
The solution conformations of ferrichrome and deferriferrichrome determined by 1H-NMR spectroscopy and computational modeling.
|
Biopolymers
|
1990
|
0.75
|
|
73
|
13C nuclear magnetic resonance of the errichrome peptides: structural and strain contributions to the conformational state.
|
J Mol Biol
|
1976
|
0.75
|
|
74
|
The aromatic 1H-NMR spectrum of plasminogen kringle 4. A comparative study of human, porcine and bovine homologs.
|
Eur J Biochem
|
1986
|
0.75
|
|
75
|
[Follow-up of people with HIV].
|
Rev Enferm
|
2006
|
0.75
|
|
76
|
Characterization of the low-field proton magnetic resonance spectrum of plasminogen kringle 4 via selective Overhauser experiments in 1H2O.
|
Biochemistry
|
1986
|
0.75
|
|
77
|
Analysis of the aromatic 1H NMR spectrum of chicken plasminogen kringle 4.
|
Arch Biochem Biophys
|
1988
|
0.75
|
|
78
|
Proton magnetic resonance study of kringle 1 from human plasminogen. Insights into the domain structure.
|
J Biol Chem
|
1986
|
0.75
|
|
79
|
Kringle-2 domain of the tissue-type plasminogen activator. 1H-NMR assignments and secondary structure.
|
Eur J Biochem
|
1991
|
0.75
|
|
80
|
Analysis of the aliphatic 1H-NMR spectrum of plasminogen kringle 4. A comparative study of human, porcine, bovine and chicken homologs.
|
Eur J Biochem
|
1988
|
0.75
|
|
81
|
Characterization of the aromatic proton magnetic resonance spectrum of crambin.
|
Biochemistry
|
1984
|
0.75
|
|
82
|
Homologous plasminogen N-terminal and plasminogen-related gene A and B peptides. Characterization of cDNAs and recombinant fusion proteins.
|
Eur J Biochem
|
1999
|
0.75
|